ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number: 1985/0002935/06 Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")
The Company refers to the disclosures made by Aspen's executive directors during a pre-‐closed period conference call with members of the investment community on 27 June 2014 ("the Conference Call") and the subsequent SENS announcement dated 30 June 2014.
Based on the representations made by the Company to the JSE, as well as the relevant facts gathered by the JSE in respect of this matter, the JSE has informed the Company that it did not find any breach of the JSE's Listings Requirements as the contents of the Conference Call were already in the public domain and/or were not materiality price sensitive if understood in its context. The investigation was thus closed by the JSE.
Durban
1 September 2014
Investec Bank Limited
distributed by |